How to Address Increasing Neurofilament Light Chain Levels

EP: 1.The Value of Biomarker in Multiple Sclerosis

EP: 2.Evolving Methods of Multiple Sclerosis Diagnosis

EP: 3.Assays to Detect Neurofilament Light

EP: 4.Challenges and Opportunity With MRI

EP: 5.Neurofilament Light Chain and Acute Gadolinium Enhancing Lesions

EP: 6.Exploring Potential Applications of Neurofilament Light Chain in MS Prognosis and Care

EP: 7.Practical Considerations for the Use of Neurofilament Light Chain and MRI

Now Viewing

EP: 8.How to Address Increasing Neurofilament Light Chain Levels

EP: 9.Weighing Treatment Decisions Based on Neurofilament Light Chain Levels

EP: 10.Monitoring Patients After a Change in Treatment Regimen

EP: 11.Assessing Lesion Types With MS Biomarkers

EP: 12.Neurofilament Light Chain and MS Prognosis, Treatment Effect, and Anticipation of Disease

EP: 13.The CLIMB Study

EP: 14.Reimbursement for MRI

EP: 15.Understanding the Underlying Progression of Multiple Sclerosis

EP: 16.Biomarkers, Patient Communication, and the Future of Care

EP: 17.Question and Answer about Neurofilament Light Chain and Other MS Biomarkers

Tanuja Chitnis, MD, expresses a preference for conducting an MRI and personally examining the patient to gather a comprehensive understanding of the situation. She emphasizes the need to identify potential asymptomatic new changes on the neurological exam. Additionally, she acknowledges that the level of comfort and confidence in interpreting NFL changes may evolve in the future.

Video synopsis is AI-generated and reviewed by HCPLive® editorial staff.